Skip to main content
Terug
Watch Compare

C21 Investments Inc.

Datakwaliteit: 83%
Ook genoteerd als CWLXF OTC
CXXIF
OTC Manufacturing Chemicals
€ 0,27
▼ € 0,01 (-4,56%)
Marktkapitalisatie: 36,43 M
Prijs
€ 0,30
Marktkapitalisatie
36,43 M
Dagbereik
52-Weeksbereik
Volume
Openen —
50D / 200D Gem.
50D / 200D Gem.

Quick Summary

Belangrijkste Punten

Capital efficient — spends only 1,35% of revenue on capex
ROIC of 1,44% — low return on invested capital

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)574,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-13,31%
Boven sectorgemiddelde (-54,44%)
ROIC1,44%
Net Margin-13,18%
Op. Margin4,26%

Veiligheid

Debt / Equity
N/A
Current Ratio0,94
Interest Coverage4,36

Waardering

PE (TTM)
-9,18
Onder sectorgemiddelde (-1,49)
P/B Ratio1,27
EV/EBITDA12,19
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -9,2 -1,5
P/B 1,3 1,6
ROE % -13,3 -54,4
Net Margin % -13,2 -41,5
Rev Growth 5Y % 1,8
D/E 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 29,22 M

All Fundamental Metrics

Growth
Revenue Growth (1Y) 574,54% Revenue Growth (3Y) -4,44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 30,12 M Net Income (TTM) -3,97 M
ROE -13,31% ROA -7,07%
Gross Margin 41,70% Operating Margin 4,26%
Net Margin -13,18% Free Cash Flow (TTM) N/A
ROIC 1,44% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,94
Interest Coverage 4,36 Asset Turnover 0,54
Working Capital -452.928 Tangible Book Value -7,96 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9,18 Forward P/E N/A
P/B Ratio 1,27 P/S Ratio 1,21
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 12,19 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 36,43 M Enterprise Value 36,43 M
Per Share
EPS (Diluted TTM) -0,03 Revenue / Share 0,24
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,35% FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Revenue 30,12 M 4,46 M 32,98 M 28,89 M
Net Income -3,97 M -74.404,0 10,92 M 293.211,0
EPS (Diluted) -0,03 0,00 0,09 0,00
Gross Profit 12,56 M 1,78 M 18,81 M 13,40 M
Operating Income 1,28 M 289.906,0 9,75 M 3,96 M
EBITDA
R&D Expenses
SG&A Expenses 11,28 M 1,49 M 9,06 M 9,45 M
D&A 1,71 M 207.225,0 1,82 M 1,84 M
Interest Expense 293.675,0 0,0 1,08 M 456.691,0
Income Tax 4,15 M 372.743,0 3,97 M 2,81 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Total Assets 57,00 M 55,23 M 61,85 M 58,31 M
Total Liabilities 28,32 M 24,25 M 26,87 M 24,00 M
Shareholders' Equity 28,68 M 30,97 M 34,98 M 34,32 M
Total Debt
Cash & Equivalents
Current Assets 7,50 M 8,14 M 10,28 M 8,74 M
Current Liabilities 7,96 M 15,05 M 14,73 M 14,97 M